{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T02:22:08Z","timestamp":1787451728443,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajgponline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jagp.2026.06.013","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:40:03Z","timestamp":1782949203000},"page":"1297-1311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neurofilament Light Chain as a Biomarker in Geriatric Psychiatry Practice: A Narrative Review"],"prefix":"10.1016","volume":"34","author":[{"given":"Quentin","family":"Gallet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques Yves","family":"Campion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lou","family":"Madieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Codron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Guillet-Pichon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoire","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Bulteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Serrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Desmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Gohier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Gouju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2026.06.013_bib0001","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018309","article-title":"Neurofilaments and neurofilament proteins in health and disease","volume":"9","author":"Yuan","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jagp.2026.06.013_bib0002","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1212\/WNL.0000000000003154","article-title":"Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia","volume":"87","author":"Rohrer","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2026.06.013_bib0003","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40520-020-01554-8","article-title":"The role of neurofilament light chain in frontotemporal dementia: a meta-analysis","volume":"33","author":"Karantali","year":"2021","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jagp.2026.06.013_bib0004","article-title":"Clinical use and reporting of neurofilament quantification in neurological disorders: a global overview","volume":"21","author":"Delaby","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jagp.2026.06.013_bib0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40520-021-02054-z","article-title":"Neurofilament light chain concentration in an aging population","volume":"34","author":"Ladang","year":"2022","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jagp.2026.06.013_bib0006","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of Plasma neurofilament light with neurodegeneration in patients with Alzheimer disease","volume":"74","author":"Mattsson","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jagp.2026.06.013_bib0007","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease in Down syndrome: a systematic review and meta-analysis","volume":"21","author":"Zhou","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jagp.2026.06.013_bib0008","article-title":"Glial fibrillary acidic protein, and neurofilament light chain as brain protein biomarkers in cerebrospinal fluid and blood for diagnosis of neurobiological diseases","volume":"25","author":"Park","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jagp.2026.06.013_bib0009","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16154","article-title":"Longitudinal course of neurofilament light chain levels in amyotrophic lateral sclerosis\u2014insights from a completed randomized controlled trial with rasagiline","volume":"31","author":"Witzel","year":"2024","journal-title":"Euro J of Neurology"},{"key":"10.1016\/j.jagp.2026.06.013_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70010","article-title":"Plasma biomarkers distinguish Boston Criteria 2.0 cerebral amyloid angiopathy from healthy controls","volume":"21","author":"Muir","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jagp.2026.06.013_bib0011","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.1002\/alz.14278","article-title":"Plasma and CSF neurofilament light chain distinguish neurodegenerative from primary psychiatric conditions in a clinical setting","volume":"20","author":"Eratne","year":"2024","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.jagp.2026.06.013_bib0012","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA\u2014a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res Integr Peer Rev"},{"key":"10.1016\/j.jagp.2026.06.013_bib0013","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/acn3.51670","article-title":"Comparison of plasma and CSF biomarkers in predicting cognitive decline","volume":"9","author":"Aschenbrenner","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jagp.2026.06.013_bib0014","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.70256","article-title":"Prognostic value of cerebrospinal fluid and serum neurofilament light chain in amyotrophic lateral sclerosis: a correlation study","volume":"15","author":"Dong","year":"2025","journal-title":"Brain Behav"},{"key":"10.1016\/j.jagp.2026.06.013_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120447","article-title":"Validation and generation of age-specific reference intervals for a new blood neurofilament light chain assay","volume":"577","author":"Booth","year":"2025","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jagp.2026.06.013_bib0016","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jagp.2026.06.013_bib0017","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76990-7","article-title":"Renal function is associated with blood neurofilament light chain level in older adults","volume":"10","author":"Akamine","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jagp.2026.06.013_bib0018","doi-asserted-by":"crossref","first-page":"25729","DOI":"10.18632\/aging.203790","article-title":"Factors influencing serum neurofilament light chain levels in normal aging","volume":"13","author":"Koini","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jagp.2026.06.013_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14630","article-title":"Sex differences in the clinical manifestation of autosomal dominant frontotemporal dementia","volume":"21","author":"Memel","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jagp.2026.06.013_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.668606","article-title":"A kinetic model for blood biomarker levels after mild traumatic brain injury","volume":"12","author":"Azizi","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.jagp.2026.06.013_bib0021","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16379","article-title":"Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: a longitudinal, multicenter study","volume":"31","author":"Meyer","year":"2024","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jagp.2026.06.013_bib0022","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.jagp.2026.06.013_bib0023","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/s41380-024-02774-4","article-title":"Blood biomarkers of neuronal injury and astrocytic reactivity in electroconvulsive therapy","volume":"30","author":"Sigstr\u00f6m","year":"2025","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jagp.2026.06.013_bib0024","article-title":"Acute neuroaxonal remodelling after electroconvulsive treatment in patients with major depressive disorder: a pilot study","volume":"18","author":"Bavato","year":"2024","journal-title":"J Affect Disord Rep"},{"key":"10.1016\/j.jagp.2026.06.013_bib0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s00415-019-09567-8","article-title":"Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders","volume":"267","author":"Katisko","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.jagp.2026.06.013_bib0026","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1007\/s00415-022-11055-5","article-title":"Plasma neurofilament light chain as a biomarker of Alzheimer\u2019s disease in subjective cognitive decline and mild cognitive impairment","volume":"269","author":"Giacomucci","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.jagp.2026.06.013_bib0027","doi-asserted-by":"crossref","first-page":"e1104","DOI":"10.1212\/WNL.0000000000008088","article-title":"Blood NfL","volume":"93","author":"Lin","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2026.06.013_bib0028","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00702-023-02632-7","article-title":"Blood neurofilament light chain in Parkinson\u2019s disease","volume":"130","author":"Buhmann","year":"2023","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.jagp.2026.06.013_bib0029","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3233\/JPD-212535","article-title":"Serum neurofilament dynamics predicts cognitive progression in de novo Parkinson\u2019s disease","volume":"11","author":"Ma","year":"2021","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.jagp.2026.06.013_bib0030","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/mds.28026","article-title":"Intraindividual neurofilament dynamics in serum mark the conversion to sporadic Parkinson\u2019s disease","volume":"35","author":"Wilke","year":"2020","journal-title":"Mov Disord"},{"key":"10.1016\/j.jagp.2026.06.013_bib0031","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","article-title":"A multicentre validation study of the diagnostic value of plasma neurofilament light","volume":"12","author":"Ashton","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jagp.2026.06.013_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.689938","article-title":"Neurofilament proteins as biomarkers to monitor neurological diseases and the efficacy of therapies","volume":"15","author":"Yuan","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jagp.2026.06.013_bib0033","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40345-023-00324-5","article-title":"Biomarkers for neurodegeneration impact cognitive function: a longitudinal 1-year case\u2013control study of patients with bipolar disorder and healthy control individuals","volume":"12","author":"Knorr","year":"2024","journal-title":"Int J Bipolar Disord"},{"key":"10.1016\/j.jagp.2026.06.013_bib0034","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jagp.2024.03.008","article-title":"Clinical accuracy of serum neurofilament light to differentiate frontotemporal dementia from primary psychiatric disorders is age-dependent","volume":"32","author":"Light","year":"2024","journal-title":"Am J Geriatr Psychiatr"},{"key":"10.1016\/j.jagp.2026.06.013_bib0035","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.bbi.2024.11.001","article-title":"Neurofilament light and glial fibrillary acidic protein in mood and anxiety disorders: a systematic review and meta-analysis","volume":"123","author":"Jy Kang","year":"2025","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jagp.2026.06.013_bib0036","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/ijnp\/pyab068","article-title":"Neurofilament light chain is a novel biomarker for major depression and related executive dysfunction","volume":"25","author":"Chen","year":"2021","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.jagp.2026.06.013_bib0037","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jpsychires.2021.05.072","article-title":"Altered neuroaxonal integrity in schizophrenia and major depressive disorder assessed with neurofilament light chain in serum","volume":"140","author":"Bavato","year":"2021","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jagp.2026.06.013_bib0038","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/schbul\/sbac135","article-title":"Neurodegeneration markers in the cerebrospinal fluid of 100 patients with schizophrenia spectrum disorder","volume":"49","author":"Runge","year":"2023","journal-title":"Schizophrenia Bullet"},{"key":"10.1016\/j.jagp.2026.06.013_bib0039","article-title":"Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia","author":"Cilia","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/j.jagp.2026.06.013_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1176266","article-title":"Plasma neurofilament light chain protein is not increased in forensic psychiatric populations: a pilot study","volume":"14","author":"Fernqvist","year":"2023","journal-title":"Front Psychiatr"},{"key":"10.1016\/j.jagp.2026.06.013_bib0041","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71060-4","article-title":"Plasma \u03b2-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia","volume":"10","author":"Rodrigues-Amorim","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jagp.2026.06.013_bib0042","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3233\/JAD-200011","article-title":"Plasma neurofilament light: a marker of neurodegeneration in mild behavioral impairment","volume":"76","author":"Naude","year":"2000","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jagp.2026.06.013_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2025.1534193","article-title":"Blood-based biomarkers in mild behavioral impairment: an updated overview","volume":"16","author":"Angelopoulou","year":"2025","journal-title":"Front Neurol"},{"key":"10.1016\/j.jagp.2026.06.013_bib0044","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1038\/s41380-024-02524-6","article-title":"Introducing neurofilament light chain measure in psychiatry: current evidence, opportunities, and pitfalls","volume":"29","author":"Bavato","year":"2024","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jagp.2026.06.013_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.754969","article-title":"Neurofilament light chain is a promising biomarker in alcohol dependence","volume":"12","author":"Li","year":"2021","journal-title":"Front Psychiatr"},{"key":"10.1016\/j.jagp.2026.06.013_bib0046","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13232","article-title":"Plasma tau, NfL, GFAP and UCHL1 as candidate biomarkers of alcohol withdrawal-associated brain damage: a pilot study","volume":"27","author":"Clergue-Duval","year":"2022","journal-title":"Addict Biol"},{"key":"10.1016\/j.jagp.2026.06.013_bib0047","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpsychires.2019.03.019","article-title":"Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia","volume":"113","author":"Al Shweiki","year":"2019","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jagp.2026.06.013_bib0048","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/acn3.51234","article-title":"Blood neurofilament light: a critical review of its application to neurologic disease","volume":"7","author":"Barro","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jagp.2026.06.013_bib0049","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1007\/s12035-023-03327-6","article-title":"A longitudinal investigation of blood neurofilament light chain levels in chronic cocaine users","volume":"60","author":"Bavato","year":"2023","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jagp.2026.06.013_bib0050","article-title":"Neurofilament light chain as a biomarker for monitoring the efficacy of transcranial magnetic stimulation on Alcohol use disorder","volume":"16","author":"Zhang","year":"2022","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.jagp.2026.06.013_bib0051","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41398-021-01209-w","article-title":"Differential longitudinal changes of neuronal and glial damage markers in anorexia nervosa after partial weight restoration","volume":"11","author":"Hellerhoff","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.jagp.2026.06.013_bib0052","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ijnp\/pyad045","article-title":"Association of neurofilament light chain with the antidepressant effects of low-dose ketamine infusion among patients with treatment-resistant depression","volume":"26","author":"Lin","year":"2023","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.jagp.2026.06.013_bib0053","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1515\/cclm-2020-1276","article-title":"Biological variation of serum neurofilament light chain","volume":"60","author":"Hviid","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jagp.2026.06.013_bib0054","doi-asserted-by":"crossref","first-page":"e1489","DOI":"10.1212\/WNL.0000000000200021","article-title":"Neurofilament light chain levels in anti-NMDAR encephalitis and primary psychiatric psychosis","volume":"98","author":"Guasp","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2026.06.013_bib0055","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/alz.12447","article-title":"Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer\u2019s disease","volume":"18","author":"Chatterjee","year":"2022","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/j.jagp.2026.06.013_bib0056","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jamaneurol.2022.5272","article-title":"Prediction of longitudinal cognitive decline in preclinical Alzheimer disease using plasma biomarkers","volume":"80","author":"Mattsson-Carlgren","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jagp.2026.06.013_bib0057","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","volume":"387","author":"Grande","year":"2016","journal-title":"The Lancet"},{"key":"10.1016\/j.jagp.2026.06.013_bib0058","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1007\/s00415-021-10714-3","article-title":"Comparative diagnosis interest of NfL and pNfH in CSF and plasma in a context of FTD-ALS spectrum","volume":"269","author":"Escal","year":"2022","journal-title":"J Neurol"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748126004367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748126004367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T02:14:18Z","timestamp":1787451258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748126004367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1064748126004367"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2026.06.013","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofilament Light Chain as a Biomarker in Geriatric Psychiatry Practice: A Narrative Review","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2026.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}